Morphine

Chemical formula: C₁₇H₁₉NO₃  Molecular mass: 285.338 g/mol  PubChem compound: 5288826

Therapeutic indications

Morphine is indicated for:

Dyspnoea of left ventricular failure and pulmonary oedema

Population group: only adults (18 years old or older)

Relief of dyspnoea of left ventricular failure and pulmonary oedema.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Severe pain

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Severe pain

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Severe pain

Population group: only children (1 year - 12 years old)

Severe pain

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Morphine is contraindicated in the following cases:

Lactation

Lactation

Acute respiratory depression, asthma attack, chronic obstructive airways disease

at least one of
Decreased respiratory function
Exacerbation of asthma
Chronic obstructive lung disease

Acute alcoholism

Alcohol intoxication

Biliary colic

Biliary colic

Head injuries

Injury of head

Coma

Coma

Increased intracranial pressure

Raised intracranial pressure

Cardiorespiratory failure

Cardiorespiratory failure

Monoamine oxidase inhibitors

Monoamine oxidase inhibitors (MAOIs)

Paralytic ileus

Paralytic ileus

Phaeochromocytoma

Phaeochromocytoma

Antibiotic-associated diarrhea, diarrhea caused by poisoning

at least one of
Antibiotic-associated diarrhea
Drug-induced diarrhea

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2019: MORPHGESIC Controlled release tablet
Structured Product Labeling (SPL/PLR) 2019: MS CONTIN Tablet
Summary of Product Characteristics (SPC) 2019: MORPHINE SULFATE Solution for injection
Structured Product Labeling (SPL/PLR) 2019: KADIAN Capsule extended-release
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈